Christopher T. Richardson

592 total citations
38 papers, 395 citations indexed

About

Christopher T. Richardson is a scholar working on Rheumatology, Epidemiology and Immunology. According to data from OpenAlex, Christopher T. Richardson has authored 38 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 11 papers in Epidemiology and 11 papers in Immunology. Recurrent topics in Christopher T. Richardson's work include Autoimmune Bullous Skin Diseases (7 papers), Systemic Lupus Erythematosus Research (7 papers) and T-cell and B-cell Immunology (7 papers). Christopher T. Richardson is often cited by papers focused on Autoimmune Bullous Skin Diseases (7 papers), Systemic Lupus Erythematosus Research (7 papers) and T-cell and B-cell Immunology (7 papers). Christopher T. Richardson collaborates with scholars based in United States, Canada and United Kingdom. Christopher T. Richardson's co-authors include Alice P. Pentland, Matthew S. Hayden, Brian Poligone, Igñacio Sanz, Douglass M. Turnbull, Scott A. Jenks, Andrew M. Schaefer, T Smith, Asiya Seema Chida and E Palmer and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Christopher T. Richardson

32 papers receiving 391 citations

Peers

Countries citing papers authored by Christopher T. Richardson

Since Specialization

Citations

This map shows the geographic impact of Christopher T. Richardson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher T. Richardson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher T. Richardson more than expected).

Fields of papers citing papers by Christopher T. Richardson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher T. Richardson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher T. Richardson. The network helps show where Christopher T. Richardson may publish in the future.

Co-authorship network of co-authors of Christopher T. Richardson

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher T. Richardson. A scholar is included among the top collaborators of Christopher T. Richardson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher T. Richardson. Christopher T. Richardson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Provider‐Based Approach to Address Racial Disparities in Lupus Clinical Trial Participation 2025 ·UNC Libraries ·(unknown), Allen Anandarajah, Saira Z. Sheikh, (unknown), Sam Lim, (unknown), (unknown), Dexter L. Cooper, (unknown), Aisha T. Langford, (unknown), (unknown), Cynthia Aranow, Donna A. Culton, (unknown), Richard M. Wardrop, (unknown), Christopher T. Richardson	0
2	Ruxolitinib cream for discoid lupus erythematosus: An open-label pilot study of 10 subjects 2024 ·Journal of the American Academy of Dermatology ·Alexandra M. Bender, (unknown), (unknown), (unknown), Christopher T. Richardson	0
3	After virus exposure, early bystander naïve CD8 T cell activation relies on NAD+ salvage metabolism 2023 ·Frontiers in Immunology ·(unknown), Barry E. Kennedy, J. Patrick Murphy, Prathyusha Konda, Michael Giacomantonio, (unknown), João A. Paulo, (unknown), Youra Kim, (unknown), Gary Sisson, Derek R. Clements, Christopher T. Richardson, Steven P. Gygi, Shashi Gujar	3
4	Successful treatment of severe chronic cutaneous lupus with anifrolumab: A series of 6 cases 2023 ·JAAD Case Reports ·(unknown), (unknown), Christopher T. Richardson	19
5	Differential effect of the 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus on different cutaneous lupus subtypes 2023 ·Journal of the American Academy of Dermatology ·(unknown), (unknown), (unknown), (unknown), Christopher T. Richardson	0
6	Wong-type dermatomyositis with interstitial lung disease and anti-SRP and -PM/Scl antibodies treated with intravenous immunoglobulin 2023 ·JAAD Case Reports ·(unknown), H. Mark Kenney, Christopher T. Richardson	2
7	NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma 2022 ·Molecular Therapy — Oncolytics ·Barry E. Kennedy, Michael Giacomantonio, J. Patrick Murphy, (unknown), (unknown), Prathyusha Konda, João A. Paulo, Gopal P. Pathak, (unknown), Stacy Grieve, Jonathan Pol, Steven P. Gygi, Christopher T. Richardson, Daniel Gaston, Tony Reiman, Guido Kroemer, Manal O. Elnenaei, Shashi Gujar	6
8	Prominent B-Cell Signature Differentiates Discoid from Subacute Cutaneous Lupus Erythematosus 2022 ·Journal of Investigative Dermatology ·Irina Lerman, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Glynis Scott, Jennifer H. Anolik, Christopher T. Richardson	9
9	Methotrexate injection site reactions: Case report and literature review 2022 ·JAAD Case Reports ·(unknown), (unknown), Christopher T. Richardson	5
10	Multiple myositis-specific autoantibodies in dermatomyositis: 2 cases and review of the literature 2022 ·JAAD Case Reports ·(unknown), Christopher T. Richardson	2
11	Molecular mechanisms responsible for SARS-CoV-2 antibody waning and vaccine escape in Omicron sublineages BA.4 and BA.5 2022 ·The Journal of Infection in Developing Countries ·(unknown), Christopher T. Richardson, Salvatore Rubino, Alyson A. Kelvin, Ali Toloue Ostadgavahi, David J. Kelvin	3
12	Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological study 2021 ·EClinicalMedicine ·(unknown), Samuel D. Searle, Ali Toloue Ostadgavahi, (unknown), (unknown), Darryl Falzarano, Salvatore Rubino, Magen E. Francis, (unknown), Christopher T. Richardson, Jason J. LeBlanc, Sharon A. Oldford, Volker Gerdts, Melissa K. Andrew, Shelly McNeil, Barry Clarke, Kenneth Rockwood, David J. Kelvin, Alyson A. Kelvin	6
13	Locally recurrent primary cutaneous coccidioidomycosis 2021 ·JAAD Case Reports ·(unknown), Glynis Scott, Sonal S. Munsiff, Christopher T. Richardson	0
14	Autoimmune progesterone dermatitis mimicking facial erythromelalgia successfully treated with hysterectomy and bilateral salpingo-oophorectomy 2020 ·JAAD Case Reports ·(unknown), (unknown), Christopher T. Richardson	2
15	Failure of B Cell Tolerance in CVID 2019 ·Frontiers in Immunology ·Christopher T. Richardson, (unknown), (unknown), (unknown), Jennifer Barnard, Arumugam Palanichamy, Igñacio Sanz, R. John Looney, Jennifer H. Anolik	10
16	A case of concurrent systemic sclerosis and scleredema 2019 ·JAAD Case Reports ·(unknown), Ritesh Agnihothri, Glynis Scott, Benjamin D. Korman, Christopher T. Richardson	1
17	Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment 2019 ·Cureus ·Irina Lerman, Christopher T. Richardson	2
18	An atypical clinical presentation of alopecia in 2 patients with systemic lupus erythematosus 2019 ·JAAD Case Reports ·Irina Lerman, Ritesh Agnihothri, Glynis Scott, Christopher T. Richardson	2
19	Molecular Basis of 9G4 B Cell Autoreactivity in Human Systemic Lupus Erythematosus 2013 ·The Journal of Immunology ·Christopher T. Richardson, Asiya Seema Chida, Diana G. Adlowitz, (unknown), (unknown), Scott A. Jenks, E Palmer, Youliang Wang, Jamie Heimburg‐Molinaro, Quan‐Zhen Li, Chandra Mohan, Richard D. Cummings, Christopher M. Tipton, Igñacio Sanz	71
20	Fludarabine phosphate and melphalan: a reduced intensity conditioning regimen suitable for allogeneic transplantation that maintains the graft versus malignancy effect 2006 ·Bone Marrow Transplantation ·Ranjit Dasgupta, Simon Rule, Peter Johnson, J. M. Davies, Alan K. Burnett, C Poynton, Keith Wilson, Graeme Smith, Graham Jackson, Christopher T. Richardson, (unknown), (unknown), Susan M. Tollerfield, Gareth J. Morgan	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact